Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 1
2005 6
2006 1
2007 6
2008 6
2009 6
2010 6
2011 2
2012 6
2013 6
2014 3
2015 4
2016 5
2017 10
2018 5
2019 5
2020 14
2021 9
2022 14
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
Scherpereel A, Opitz I, Berghmans T, Psallidas I, Glatzer M, Rigau D, Astoul P, Bölükbas S, Boyd J, Coolen J, De Bondt C, De Ruysscher D, Durieux V, Faivre-Finn C, Fennell D, Galateau-Salle F, Greillier L, Hoda MA, Klepetko W, Lacourt A, McElnay P, Maskell NA, Mutti L, Pairon JC, Van Schil P, van Meerbeeck JP, Waller D, Weder W, Cardillo G, Putora PM. Scherpereel A, et al. Among authors: mutti l. Eur Respir J. 2020 Jun 11;55(6):1900953. doi: 10.1183/13993003.00953-2019. Print 2020 Jun. Eur Respir J. 2020. PMID: 32451346 Free article.
Neuro-Immune Interactions in Severe COVID-19 Infection.
Rossi E, Mutti L, Morrione A, Giordano A. Rossi E, et al. Among authors: mutti l. Pathogens. 2022 Oct 29;11(11):1256. doi: 10.3390/pathogens11111256. Pathogens. 2022. PMID: 36365007 Free PMC article. Review.
Anti-CTLA-4 therapy for malignant mesothelioma.
Guazzelli A, Bakker E, Krstic-Demonacos M, Lisanti MP, Sotgia F, Mutti L. Guazzelli A, et al. Among authors: mutti l. Immunotherapy. 2017 Mar;9(3):273-280. doi: 10.2217/imt-2016-0123. Immunotherapy. 2017. PMID: 28231719 Free article. Review.
Immunotherapy advances for mesothelioma treatment.
Bakker E, Guazzelli A, Ashtiani F, Demonacos C, Krstic-Demonacos M, Mutti L. Bakker E, et al. Among authors: mutti l. Expert Rev Anticancer Ther. 2017 Sep;17(9):799-814. doi: 10.1080/14737140.2017.1358091. Epub 2017 Jul 31. Expert Rev Anticancer Ther. 2017. PMID: 28724330 Free article. Review.
The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review.
Nardone V, Romeo C, D'Ippolito E, Pastina P, D'Apolito M, Pirtoli L, Caraglia M, Mutti L, Bianco G, Falzea AC, Giannicola R, Giordano A, Tagliaferri P, Vinciguerra C, Desideri I, Loi M, Reginelli A, Cappabianca S, Tassone P, Correale P. Nardone V, et al. Among authors: mutti l. Radiol Med. 2023 Mar;128(3):316-329. doi: 10.1007/s11547-023-01602-z. Epub 2023 Feb 14. Radiol Med. 2023. PMID: 36786970 Free PMC article. Review.
Editorial: Prognostic factors in non-small cell lung cancer.
Rahouma M, Baudo M, Zhang J, Mutti L. Rahouma M, et al. Among authors: mutti l. Front Oncol. 2023 Mar 14;13:1174625. doi: 10.3389/fonc.2023.1174625. eCollection 2023. Front Oncol. 2023. PMID: 36998444 Free PMC article. No abstract available.
Abemaciclib for malignant pleural mesothelioma.
Nardone V, Porta C, Giannicola R, Correale P, Mutti L. Nardone V, et al. Among authors: mutti l. Lancet Oncol. 2022 Jun;23(6):e237. doi: 10.1016/S1470-2045(22)00276-5. Lancet Oncol. 2022. PMID: 35654054 No abstract available.
127 results